The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Urinary Tract Obstruction Treatment Devices Market Compare Between 2026 And 2030?
The urinary tract obstruction treatment devices market has demonstrated substantial growth in recent years. It is anticipated to increase from $1.4 billion in 2025 to $1.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. This historical expansion can be linked to several factors, including a rise in kidney stone prevalence, the growth of the aging population, an increase in BPH incidence, the expansion of hospital urology departments, and the growth in catheterization procedures.
The market size for urinary tract obstruction treatment devices is projected to experience robust expansion over the coming years. This market is set to reach $1.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period stems from factors such as laser-based urology adoption, outpatient obstruction treatments, advanced stent biomaterials, robotic-assisted urology procedures, and efforts to reduce hospital stays. Significant developments expected over the forecast period encompass minimally invasive obstruction management, advanced laser lithotripsy systems, improved ureteral stent designs, endoscopic stone removal techniques, and solutions for quicker post-procedure recovery.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Drivers Are Supporting The Urinary Tract Obstruction Treatment Devices Market Growth?
A growing incidence of kidney disease is anticipated to stimulate the expansion of the urinary tract obstruction treatment devices market. This condition refers to impaired or damaged kidneys, which hinders their capacity to remove waste and excess fluids from the blood. Its occurrence is escalating due to factors like aging demographics, higher rates of diabetes and hypertension, and unhealthy living habits. Medical intervention becomes necessary for kidney disease patients to alleviate renal pressure and maintain kidney function. Progression of the disease often results in more frequent urinary tract obstructions, thereby escalating the demand for devices used to manage and prevent further renal harm. For example, a report from June 2023 by Kidney Research UK, a non-profit organization based in the UK, indicated that approximately 7.2 million people in the UK currently suffer from chronic kidney disease, accounting for over 10% of the population. Within this group, 3.25 million are in advanced stages, while 3.9 million are in early stages. Projections suggest that by 2033, the count of individuals impacted by chronic kidney disease will climb to 7.61 million. Consequently, the expanding prevalence of kidney disease is anticipated to fuel the growth of the urinary tract obstruction treatment devices market.
How Are Different Segments Classified In The Urinary Tract Obstruction Treatment Devices Market Segment Analysis?
The urinary tract obstruction treatment devices market covered in this report is segmented –
1) By Type: Urinary Catheter, Ureteroscope, Shock Wave Lithotripters, Laser Therapy Systems, Other Types
2) By Application: Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis
3) By End-User: Hospitals, Ambulatory Surgical Centers, Surgical Centers, Other End-Users
Subsegments:
1) By Urinary Catheter: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters, Hydrophilic-Coated Urinary Catheters
2) By Ureteroscope: Rigid Ureteroscopes, Flexible Ureteroscopes, Semi-Rigid Ureteroscopes, Digital Ureteroscopes
3) By Shock Wave Lithotripters: Extracorporeal Shock Wave Lithotripters (ESWL), Pneumatic Shock Wave Lithotripters, Electrohydraulic Shock Wave Lithotripters, Laser-Assisted Shock Wave Lithotripters
4) By Laser Therapy Systems: Holmium Laser Therapy Systems, Thulium Laser Therapy Systems, Diode Laser Therapy Systems, Nd:YAG Laser Therapy Systems
5) By Other Types: Stents For Urinary Tract Obstruction, Percutaneous Nephrostomy Devices, Ureteral Balloon Dilation Catheters, Ureteral Access Sheaths, Urological Drainage Devices
Which Trends Are Expected To Impact The Urinary Tract Obstruction Treatment Devices Market?
Leading companies in the urinary tract obstruction treatment devices market are prioritizing minimally invasive, retrievable prostatic implants. These solutions aim to offer reversible, outpatient options that alleviate obstruction while preserving tissue and function. A retrievable prostatic stent is a compact, implantable nitinol device inserted cystoscopically into the prostatic urethra, designed to restore urine flow without surgery and can be removed or replaced as needed. For instance, in April 2025, Rivermark Medical, a US-based medical device company, commenced the pivotal RAPID-III trial for its FloStent system. This system is a minimally invasive nitinol prostatic implant engineered to relieve lower urinary tract symptoms stemming from benign prostatic hyperplasia (BPH) as a first-line, reversible outpatient treatment. The FloStent system is intended to provide an alternative to medication and more invasive surgical procedures by gently expanding the prostatic urethra to enhance urinary flow. The study is anticipated to produce crucial clinical evidence regarding safety, durability, and improvements in patient quality of life, thereby supporting the broader adoption of this implant-based method for managing BPH.
Who Are The Companies Driving Activity In The Urinary Tract Obstruction Treatment Devices Market?
Major companies operating in the urinary tract obstruction treatment devices market are Medtronic Plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast Corporation, Smiths Group plc, Bio-Rad Laboratories, Teleflex Incorporated, Paul Hartmann AG, Karl Storz SE & Co. KG, Cook Medical, Hollister Incorporated, Amsino International Inc., Richard Wolf GmbH, Braun Melsungen AG, Angiplast Pvt. Ltd., Mais India Medical Devices Pvt. Ltd., Convatec Inc., VYGON (UK) LTD., United Endoscopy, Advin Health Care, Manish Medi Innovation, MicroPort Urocare (Jiaxing) Co. Ltd., Nikotech Pvt Ltd.
Get The Full Urinary Tract Obstruction Treatment Devices Market Report:
Which Region Has The Greatest Market Share In The Urinary Tract Obstruction Treatment Devices Market?
North America was the largest region in the urinary tract obstruction treatment devices market in 2025. The regions covered in the urinary tract obstruction treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Urinary Tract Obstruction Treatment Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Urinary Tract Obstruction Treatment Devices Market 2026, By The Business Research Company
Uncomplicated Urinary Tract Infection Treatment Market Report 2026
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model